The Prescription Drug User Fee Act of
1992 as amended by the Food and Drug Administration Modernization
Act of 1997 (PDUFA 1992/FDAMA 1997) and the Prescription Drug User
Fee Amendments of 2002, reauthorizes of 2002, reauthorizes the
assessment and use of fees relating to human drugs and licensed
biologic products. The User Fee Cover Sheet, Form FDA 3397, is used
to acount for and track User Fees reauthorized by PDFUA 1992/FDAMA
1997/PDUFA 2003. The form requests the minumum information
necessary to determine whether a fee is required for review of
human drug or licensed biologic product.......
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.